Researchers at an autoimmune community gathering discussed how GLP-1 drugs are shifting thinking about health beyond the scale. Details are thin.
Recap by typeshit. Post by Facebook on Facebook.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
After six months of injections barely moved the scale, she was diagnosed with lipedema and spent about $80,000 CAD on four surgeries in Madrid.
Novo Nordisk India's managing director Vikrant Shrotriya told Financial Express he sees steady growth even as cheaper generics move in, per Investseekers.
Loading…